Neurogastrx To Present NG101 Data Reducing GLP-1 Related Nausea
07 Oct 2025 //
GLOBENEWSWIRE
Neurogastrx Announces Positive Data For NG101 In Reducing Nausea
16 Oct 2024 //
GLOBENEWSWIRE
Daewoong Regaining Rights to Fexuprazan in the USA and Canada
05 Jun 2023 //
PR NEWSWIRE
Neurogastrx assembles ex-Ironwood team with $60M
27 Aug 2021 //
FIERCE BIOTECH
After pandemic delay & a South Korean deal, Boston-area biotech raises Series B
26 Aug 2021 //
ENDPTS

Market Place
Sourcing Support